Last update 19 Jun 2025

Bone marrow-derived allogeneic MSCs(University Medical Center of Utrecht)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms-
Target-
Action-
Mechanism
Stem cell replacements
Therapeutic Areas
Nervous System DiseasesCardiovascular Diseases
Active Indication-
Inactive Indication
Infarction, Middle Cerebral ArteryPerioperative ischaemia
Originator Organization
University Medical Center of UtrechtUniversity Medical Center of Utrecht
Active Organization-
Inactive Organization
University Medical Center of UtrechtUniversity Medical Center of Utrecht
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Bone marrow-derived allogeneic MSCs(University Medical Center of Utrecht)
NCT03356821
/ CompletedPhase 1/2IIT
Adult Mesenchymal Stromal Cells to Regenerate the Neonatal Brain: the PASSIoN Trial (Perinatal Arterial Stroke Treated With Stromal Cells IntraNasally)
100 Clinical Results associated with Bone marrow-derived allogeneic MSCs(University Medical Center of Utrecht)
Login to view more data
100 Translational Medicine associated with Bone marrow-derived allogeneic MSCs(University Medical Center of Utrecht)
Login to view more data
100 Patents (Medical) associated with Bone marrow-derived allogeneic MSCs(University Medical Center of Utrecht)
Login to view more data
100 Deals associated with Bone marrow-derived allogeneic MSCs(University Medical Center of Utrecht)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Infarction, Middle Cerebral ArteryPhase 2
Netherlands
University Medical Center of UtrechtUniversity Medical Center of Utrecht
11 Feb 2020
Perioperative ischaemiaPhase 2
Netherlands
University Medical Center of UtrechtUniversity Medical Center of Utrecht
11 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03356821 (PASSIoN, CTgov)
Phase 1/2
Stroke | Perioperative ischaemia | Infarction, Middle Cerebral Artery
10
grvzppestw = whnwoiaxpk jzxbuulhcs (diamfvxohz, zdhlsvqvkw - nahypqsfmn)
View more
-
13 May 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free